Credible Market Trends Augmenting the Growth of the Global Anti-Malaria Drugs Market
Imperial and GSK signed a collaborative agreement to work on the development of antimalarial agents targeting N-myristoyltransferase (NMT). This collaboration was brought in association to expand the already existing anti-malaria offering product portfolio of GSK.
Bayer announced the establishment of a partnership with Goodbye Malaria which is expected to jointly eliminate malaria in Mozambique and Swaziland by the year 2030. The company can gain crucial insights from implementation challenges associated with IRS through this alliance.
Many countries of the world are prone to the risk of malaria transmission which has driven large number of partners and resources to rapidly increase malaria control efforts and efficient management strategies such as prevention control, resources for early diagnosis and efficient anti-malaria drugs to minimize the effects. The worldwide demand for anti-malaria drugs is increasing on the back of massive growth of healthcare industry across the globe. Further, increasing awareness about early symptoms, constant monitoring and easy availability of therapeutics is predicted to benefit the expansion of the global anti-malaria drugs market with a CAGR of 3.2% over the forecast period i.e. 2018-2027. The global anti-malaria drugs market accounted for USD 742.5 Million in 2016 and is predicted to reach USD 1,049.5 Million in 2027. The market is expected to grow with a Y-O-Y growth rate of 3.4% in the year 2027.
Download Sample of This Strategic Report:
Growth Highlights based upon Regional Platform during 2016-2027
The global anti-malaria drugs market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa, out of which, Middle East & Africa anti-malaria drugs market accounted for more than 50% of the market share during 2016 which can be attributed to growing rate of malaria cases and lack of resources to control the local transmission of the disease in this region. Further, the Middle East & Africa is believed to dominate the overall anti-malaria drugs market during the forecast period.
The second largest share of 30% was held by the Asia Pacific anti-malaria drugs market which is anticipated to cross USD 300 Million by 2027. China & India are the major contributors behind the growth of the Asia Pacific anti-malaria drugs market.
Market Segmentation Synopsis
By Anti-malaria Activity
Global anti-malaria drugs market is segmented on the basis of anti-malaria activity into tissue schizonticides, blood schizonticides, gametocytocides, sporontocides & others. Among these segments, gametocytocides segment with 60.3% share in 2016, occupied the largest market of anti-malaria drugs across the globe. These drugs destroy the sexual forms of the parasite in the blood and thereby prevent transmission of the infection to the mosquito which is predicted to be the driving factor behind the positive growth of gametocytocides segment throughout the forecast period. Additionally, blood schizonticides segment held the second largest share of anti-malaria drugs market and is expected to achieve Y-o-Y growth rate of 3.4% in 2027.
By Drug Chemistry
The global anti-malaria drugs market is divided by drug chemistry into aryl amino alcohols, 4-aminoquinolines, folate synthesis inhibitors, 8-aminoquinolines, antimicrobials, peroxides, napthoquinones, iron chelating agents and others. Among these segments, the 4-aminoquinolines segment is estimated to capture the highest market share during the forecast period. This segment contributed around 26% market share of the total anti-malaria drugs market in 2016 and is projected to achieve Y-o-Y growth rate of 3.7% in 2027 as compared to previous year. Further, the 8-aminoquinolines and napthoquinones segment are estimated to grow significantly over the forecast period.
By Distribution Channel
The global market of anti-malaria drugs market is segmented by distribution channel into hospital pharmacy, retail pharmacy and others, out of which, the retail pharmacy segment contributed around 60% market share of the total anti-malaria drugs market in 2016 and is estimated to remain highest during the forecast period by expanding at a highest CAGR of 3.4% during the period 2018-2027. Further, hospital pharmacy segment is projected to achieve Y-o-Y growth rate of 3.3% in 2027.
The study further analysis the Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).
Market Drivers & Challenges
The global anti-malaria drugs market is thriving on the back of growing rate of malaria effected fatalities around the globe. According to World Health Organization, in 2016, nearly half of the world’s population was at risk of malaria. Also, most malaria cases and deaths occur in sub-Saharan Africa. In 2016, 91 countries and areas had ongoing malaria transmission as reported by W.H.O. The increasing prevalence of malaria due to changing environmental conditions, as well as increasing poverty in certain parts of the world is predicted to increase the demand for anti-malaria drugs over the forecast period.
Further, a number of promising anti-malaria drug discovery projects are being funded by the Medicines for Malaria Venture (MMV), a non-profit organization focused on anti-malaria drug discovery which is anticipated to lure giant market players into the research and developmental activity for anti-malaria drugs market. The growing demand for outcome based, preventive healthcare is estimate to increase the demand for anti-malaria drugs over the forecast period and is believed to aid the anti-malaria drugs market to expand during the forecast period.
Procure this Market Intelligence Report:
About Kenneth Research:
Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.
Email: [email protected]
Phone: +1 313 462 0609